Key facts
- It has raised $5.7M; the latest was Early Stage VC in Jan 2025.
- Notable investors include Alumni Ventures, Goodwater Capital, Connecticut Innovations, City Light Capital, Breyer Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Jona
- ·The full record, as it builds
Funding rounds
No funding rounds for Jona are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jona
Developer of an artificial intelligence-powered microbiome profiling platform designed to interpret microbiome tests and improve digestive health. The company's platform profiles microbiome with deep metagenomics technology that analyzes bacteria, fungi, viruses, and protists that provide a map of associations to critical health conditions, symptoms, food sensitivities, and recommended actions for diet, exercise, sleep, and treatments, enabling patients to find relief and be proactive in an era of rising chronic illness.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Website
- jona.health/
- Ownership
- Privately Held (backing)
Jona doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jona shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jona in its N-PORT filings yet. We sweep new filings monthly.